Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 58 matching records.
58 results — page 1 of 3
- Level DNarrative ReviewEurope PMC
Perianal Crohn's Disease in Inflammatory Bowel Disease: Diagnosis, Assessment and Treatment
Narrative Review on Autoimmune Research, published in Life (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Life (Basel) - Level ASystematic ReviewEurope PMC
Intraoperative Autologous Adipose-Derived Therapies and PRP as Add-On in the Surgical Treatment of Cryptoglandular and Crohn's Disease-Related Perianal Fistula-A Systematic Review
Systematic Review with a reported sample of 1017 on Autoimmune Research, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 1017
Bioengineering (Basel) - Level DNarrative ReviewEurope PMC
Unveiling Genital Crohn's Disease: Clinical Complications, Diagnosis, and Treatment, a Comprehensive Review of Case Reports
Narrative Review on Immune Modulation, Autoimmune Research, published in Gastro Hep Adv (2026) — summary generated from the PubMed abstract.
- 2026
Gastro Hep Adv - Level DLaboratory StudyEurope PMC
Global trends in surgically based treatment of anal fistula in Crohn's disease: a bibliometric and visualization analysis
Laboratory Study on Autoimmune Research, published in Int J Surg (2025) — summary generated from the PubMed abstract.
- 2025
Int J Surg2 citations - Level DNarrative ReviewEurope PMC
Fistula in Crohn's disease: classification, pathogenesis, and treatment options
Narrative Review on Autoimmune Research, published in Tissue Barriers (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Barriers6 citations - Level AMeta-analysisPubMed
Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 596 on Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 596
Stem Cell Res Ther6 citations - Level CProspective StudyPubMed
Predictive Factors of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Therapy's Success in the Treatment of Perianal Fistulas in Patients With Crohn's Disease.
Prospective Study on Autoimmune Research, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level CProspective StudyEurope PMC
Treatment of chronic anal fissure in Crohn's disease patients with freshly collected autologous adipose tissue: a pilot study
Prospective Study with a reported sample of 4 on Chronic Wound, Autoimmune Research, published in Tech Coloproctol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 4
Tech Coloproctol - Level DNarrative ReviewEurope PMC
Management and Treatment of Perianal Fistulizing Crohn's Disease
Narrative Review on Autoimmune Research, published in Clin Exp Gastroenterol (2025) — summary generated from the PubMed abstract.
- 2025
Clin Exp Gastroenterol - Level BClinical TrialPubMed
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.
Clinical Trial on Osteoarthritis, Chronic Wound, Chronic Inflammation, Autoimmune Research, published in BMJ Open (2025) — summary generated from the PubMed abstract.
- 2025
BMJ Open - Level CProspective StudyPubMed
Insights into treatment of complex Crohn's perianal fistulas.
Prospective Study on Autoimmune Research, published in BMC Proc (2024) — summary generated from the PubMed abstract.
- 2024
BMC Proc2 citations - Level CProspective StudyPubMed
[A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan].
Prospective Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Nihon Yakurigaku Zasshi (2024) — summary generated from the PubMed abstract.
- 2024
Nihon Yakurigaku Zasshi - Level CRetrospective StudyPubMed
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study.
Retrospective Study with a reported sample of 223 on Autoimmune Research, published in Aliment Pharmacol Ther (2024) — summary generated from the PubMed abstract.
- 2024
- n = 223
Aliment Pharmacol Ther - Level AMeta-analysisPubMed
Optimizing Treatment Outcomes in Crohn's Disease: A Comprehensive Systematic Review and Meta-Analysis of Regenerative Therapies with Emphasis on Platelet-Rich Plasma.
Meta-analysis with a reported sample of 138 on Autoimmune Research, published in Pharmaceuticals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
- n = 138
Pharmaceuticals (Basel)2 citations - Level BClinical TrialPubMed
Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease.
Clinical Trial with a reported sample of 513 on Autoimmune Research, published in BMC Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 513
BMC Gastroenterol1 citations - Level CProspective StudyPubMed
Platelet-Rich stroma from Crohn's disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls.
Prospective Study on Autoimmune Research, published in Stem Cell Res (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res6 citations - Level DNarrative ReviewPubMed
Stem cells in treatment of crohn's disease: Recent advances and future directions.
Narrative Review on Autoimmune Research, published in Transpl Immunol (2023) — summary generated from the PubMed abstract.
- 2023
Transpl Immunol4 citations - Level CCohort StudyPubMed
Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.
Cohort Study with a reported sample of 8 on Scar, Autoimmune Research, published in Wien Klin Wochenschr (2023) — summary generated from the PubMed abstract.
- 2023
- n = 8
Wien Klin Wochenschr9 citations - Level BClinical TrialEurope PMC
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study
Clinical Trial with a reported sample of 10 on Autoimmune Research, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
- n = 10
Stem Cell Res Ther14 citations - Level BClinical TrialPubMed
The history of Crohn's perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel.
Clinical Trial on Autoimmune Research, published in Expert Opin Biol Ther (2023) — summary generated from the PubMed abstract.
- 2023
Expert Opin Biol Ther1 citations - Level BRandomized Controlled TrialPubMed
Stem Cell Therapy for the Treatment of Crohn's Disease; Current Obstacles and Future Hopes.
Randomized Controlled Trial on Autoimmune Research, published in Curr Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Curr Stem Cell Res Ther - Level BRandomized Controlled TrialPubMed
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Randomized Controlled Trial with a reported sample of 25 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 25
Dis Colon Rectum103 citations - Level CProspective StudyPubMed
Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot study.
Prospective Study with a reported sample of 24 on Autoimmune Research, published in Aliment Pharmacol Ther (2022) — summary generated from the PubMed abstract.
- 2022
- n = 24
Aliment Pharmacol Ther9 citations - Level BClinical TrialPubMed
Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2021) — summary generated from the PubMed abstract.
- 2021
- n = 20
Dis Colon Rectum
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406